『Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice』がLife Sciences 2021 Jan 4;268:119014.doi: 10.1016/j.lfs.2020.119014.に掲載されました。

Life Sciences 2021 Jan 4;268:119014.doi: 10.1016/j.lfs.2020.119014